Shanghai Rendu Biotechnology Co

Shanghai Rendu Biotechnology Co Graham Number

The Graham Number of Shanghai Rendu Biotechnology Co (688193.SS) as of Oct 29, 2026 is 11.38 CNY. In the previous year, Graham Number was 10.57 CNY — a change of 7.67% (higher).

Graham Number

11.38CNY

YoY

7.67%

Last updated:

Graham Number of Shanghai Rendu Biotechnology Co is 2025 11.38 CNY. Graham Number of Shanghai Rendu Biotechnology Co was 2024 10.57 CNY. It decreases by 7.67% higher compared to the previous year.

The Shanghai Rendu Biotechnology Co Graham Number history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Graham Number
Date
Graham Number
Jan 1, 2019
2.81 CNY
Jan 1, 2020
13.61 CNY
Jan 1, 2021
16.16 CNY
Jan 1, 2022
17.74 CNY
Jan 1, 2023
10.57 CNY
Jan 1, 2025
11.38 CNY
The Shanghai Rendu Biotechnology Co Graham Number history
YEARGraham NumberYoY
11.38CNY+7.67%
10.57CNY-40.46%
17.74CNY+9.83%
16.16CNY+18.69%
13.61CNY+384.03%
2.81CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co., Ltd. generates revenue through the sale of molecular diagnostic tests and medical instruments. The company develops diagnostic reagents using RNA isothermal amplification technology, including respiration series, reproduction series, enterovirus series, and blood-borne diseases series. These products are sold domestically within China, targeting healthcare providers and laboratories that require rapid and accurate diagnostic solutions. The firm's focus on domestic market sales ensures consistent demand for its specialized reagents and instruments. The company's product portfolio includes multiple series of diagnostic reagents designed for specific health conditions, such as respiratory and reproductive health. Medical instruments are also manufactured and sold alongside these reagents. Domestic sales within China form the primary revenue stream, with no mention of international markets or additional product lines. The firm's technology and product offerings cater to the needs of medical professionals seeking efficient diagnostic tools. Shanghai Rendu Biotechnology's business model relies on the domestic market for all product sales, with no indication of export or international partnerships. The company's workforce of 528 full-time employees supports the development, manufacturing, and sales of its diagnostic reagents and instruments. Revenue is derived solely from the sale of these products within China, without any reference to third-party collaborations or additional services. Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

Graham Number of Shanghai Rendu Biotechnology Co is 11.38 CNY in 2025.

On Eulerpool you can find the complete historical development of Graham Number Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Shanghai Rendu Biotechnology Co

All Key Metrics — Shanghai Rendu Biotechnology Co